PREVIOUS
✖
safeEXO-Cas
June 14 , 2024
197 days
298
0
- The Researchers have developed an exosome-based platform, "safeEXO-Cas."
- It significantly enhances the delivery of CRISPR/Cas9 genome editing components to specific cells and tissues.
- CRISPR/Cas9 is a unique technology that enables geneticists and medical researchers to edit parts of the genome by removing, adding or altering sections of the DNA sequence.
Leave a Reply
Your Comment is awaiting moderation.